Recent updates

  • 14 Nov 2018 First-in-class treatment approved in the US for relapsed or refractory hairy cell leukemia Topic: Hairy cell leukemia
  • 13 Nov 2018 Ebola outbreak in DRC: case numbers exceed 300 as outbreak enters fourth month Topic: Ebola virus infection
  • 09 Nov 2018 US guidelines now recommend doravirine for the treatment of HIV Topic: HIV infection
  • 30 Oct 2018 Reversible posterior leukoencephalopathy syndrome in patients receiving ponatinib Topic: Chronic myelogenous leukemia
  • 26 Oct 2018 Inotersen and patisiran approved in the US for the treatment of polyneuropathy in adults with hereditary TTR amyloidosis Topic: Amyloidosis
  • 25 Oct 2018 Safety alert for ponatinib following reports of posterior reversible encephalopathy syndrome Topic: Acute lymphocytic leukemia
  • 19 Oct 2018 Expert review recommends against use of decongestants in children under 6 years of age Topic: Common cold
  • 19 Oct 2018 Expert review recommends against use of decongestants in children under 6 years of age Topic: Common cold
  • 16 Oct 2018 FDA approves three CGRP inhibitors for the prevention of migraine Topic: Migraine headache in adults
  • 10 Oct 2018 New daclizumab alert: encephalitis cases reported several months after discontinuation Topic: Multiple sclerosis
  • 20 Sep 2018 CDC alerts clinicians to a 'dramatic rise' in overdose deaths from fentanyl and its analogs Topic: Opioid overdose
  • 18 Sep 2018 Corticosteroids reduce mortality but increase neuromuscular weakness in sepsis and septic shock Topic: Sepsis in adults
  • 13 Sep 2018 Cannabidiol approved by the Food and Drug Administration (FDA) to treat rare, severe forms of epilepsy in children Topic: Generalized seizures in children
  • 16 Aug 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Brain abscess
  • 14 Aug 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Migraine headache in adults
  • 09 Aug 2018 CDC shortens waiting period for conception after Zika exposure Topic: Zika virus infection
  • 13 Jul 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Huntington disease
  • 13 Jul 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Bipolar disorder in children
  • 03 Jul 2018 Sepsis patients who receive prolonged infusion of antipseudomonal beta-lactam antibiotics are 30% less likely to die, meta-analysis finds Topic: Sepsis in adults
  • 29 Jun 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Seasonal affective disorder
  • 29 Jun 2018 US guidance now recommends consideration of intrapartum zidovudine in women with detectable viral loads <1000 copies/mL Topic: HIV infection in pregnancy
  • 19 Jun 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Suicide risk management
  • 06 Jun 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Absence seizures
  • 06 Jun 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Focal seizures
  • 31 May 2018 US CDC no longer recommends dolutegravir as part of PEP regimen in early pregnancy or women of childbearing age Topic: Post-exposure HIV prophylaxis
  • 30 May 2018 US and EU drug regulators warn of possible increased risk of neural tube defects in babies born to women taking dolutegravir Topic: HIV infection in pregnancy
  • 18 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Generalized seizures in children
  • 18 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Generalized seizures
  • 18 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Migraine headache in children
  • 18 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Schizoaffective disorder
  • 15 May 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Bipolar disorder in adults
  • 11 Oct 2017 Landmark cohort study on long-term antiplatelet treatment use in over-75s (post myocardial infarction/stroke/TIA) and risk of major GI bleeding Topic: Transient ischemic attack